Retrophin’s kidney drug succeeds in mid-stage study

(Reuters) – Retrophin Inc said its rare kidney disorder drug met the main goal of a mid-stage study.

(Reuters) – Retrophin Inc said its rare kidney disorder drug met the main goal of a mid-stage study.
Original Article

more recommended stories